RG
ZVRA icon

Retirement Group’s Zevra Therapeutics ZVRA Stock Holding History

Retirement Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-200
Closed -$1.31K – 876
2023
Q4 		$1.31K Hold
200
– – ﹤0.01% 682
2023
Q3 		$964 Hold
200
– – ﹤0.01% 643
2023
Q2 		$1.02K Hold
200
– – ﹤0.01% 667
2023
Q1 		$1K Hold
200
– – ﹤0.01% 673
2022
Q4 		$1K Hold
200
– – ﹤0.01% 617
2022
Q3 		$1K Sell
200
-200
-50% -$1.13K ﹤0.01% 461
2022
Q2 		$2K Hold
400
– – ﹤0.01% 651
2022
Q1 		$2K Hold
400
– – ﹤0.01% 649
2021
Q4 		$3K Hold
400
– – ﹤0.01% 597
2021
Q3 		$4K Hold
400
– – ﹤0.01% 476
2021
Q2 		$5K Hold
400
– – ﹤0.01% 504
2021
Q1 		$4K Buy
+400
New +$3.49K ﹤0.01% 591

Other funds holding ZVRA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Retirement Group's ZVRA Position: Q1 2024 in Review

Retirement Group sold out of Zevra Therapeutics (ZVRA) in Q1 2024, closing a stake of 200 shares — an estimated $1.31K sold.

Retirement Group first reported a position in ZVRA in Q1 2021 and held it in 12 quarters. The position peaked at $5K in Q2 2021. 89 funds tracked by Wall St. Rank hold ZVRA as of Q1 2024.

  • Retirement Group reported no remaining Zevra Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Retirement Group sold 200 Zevra Therapeutics shares in Q1 2024, an estimated $1.31K.
  • Retirement Group first reported a position in Zevra Therapeutics in Q1 2021 and held it in 12 quarters.
  • Retirement Group's Zevra Therapeutics position peaked at $5K in Q2 2021.
  • 89 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.